ClinicalTrials.gg
RecruitingNCT07178223TRACEUpdated Sep 23, 2025

TRACE - Thumb Base Replacement Arthroplasty for Osteoarthritis.

An interventional study of Arthroplasty CMC-1 in Osteoarthritis of the CMC-1 Joint, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Osteoarthritis with a site in Sweden — 12 open to participants now, 25 under way, none of them phase 3. Osteoarthritis · Sweden.

Planned enrollment
30th of 57
90 · median 98
Started
2025
with 3 others
No phase
41 of 78
6 open now
Primary completion
2038-12
later than 24 of 24 live
Registered
75th of 78
by date
Lead sponsor
7 of 78
Karolinska Institutet

Among the 78 studies in Osteoarthritis with a site in Sweden, this one is the 30th largest by planned enrollment of the 57 interventional ones that give a count, is one of 4 that started in 2025, is one of 41 with no phase, reaches primary completion later than 24 of the 24 other live ones, and was the 75th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

12 of the 78 studies in Osteoarthritis with a site in Sweden are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Osteoarthritis with a site in Sweden, or all of them as a file.
02

Study summary

Osteoarthritis in the base of the thumb is one of the most common forms of hand arthritis. It usually appears in middle age, particularly in women, and can cause significant pain and loss of function. Early treatment often includes splints, painkillers, joint protection techniques, or steroid injections. If these measures are not enough, surgery is considered.

The current standard operation in Sweden is trapeziectomy-removing the trapezium. This usually gives good pain relief at rest, but many patients continue to experience pain when loading the hand and reduced grip strength. Another surgical option is trapeziometacarpal limited excision (TLE), where only part of the bone is removed to keep the thumb slightly longer, which may improve strength. Both procedures are non-implant surgeries.

A newer alternative is total joint arthroplasty (TJA), where the joint is replaced with a prosthesis. Early studies suggest that this may allow for quicker recovery and possibly better strength compared to trapeziectomy. However, it is more expensive and carries higher risks, such as implant loosening or dislocation. So far, research has not proven that it offers better long-term results.

The TRACE study (A single arm trial of Thumb base Replacement Arthroplasty for osteoarthritis Compared to External controls) is designed to help answer this question. Instead of randomizing patients, this study will follow a group of people receiving thumb joint replacement and compare them to an existing group of patients who already took part in a randomized trial of trapeziectomy and TLE. This design allows the researchers to study results more quickly and with fewer resources, while still ensuring meaningful comparisons.

The main research question of this study is whether joint replacement gives better pain relief when loading the thumb 10 years after surgery compared to traditional non-implant operations in patients with painful thumb base osteoarthritis. Secondary questions include whether joint replacement improves patient-reported outcomes, hand function, and strength, and whether it leads to more or fewer complications at 1, 3, and 5 years after surgery.

90 patients will be included in the replacement group, using a dual mobility prosthesis. Their outcomes will be compared with 90 patients from the earlier trial (45 trapeziectomy and 45 limited trapeziometacarpal joint resection - TLE). The study will track pain, daily hand function, strength, range of motion, and complications such as infection or the need for further surgery. Data will be collected regularly for up to 10 years.

03

Conditions studied

  • Osteoarthritis of the CMC-1 Joint

Browse trials for

Keywords

  • cmc-1
  • osteoarthritis
  • thumb base
  • Arthroplasty
  • prosthesis
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Osteoarthritis in the thumb base. Radiological Eaton class 1-3 (Ladd et al. 2015).
  • Clinical signs of thumb base osteoarthritis: pain at palpation of the CMC-1 joint and pain during provocation/grinding test.

The inclusion criteria are identical to those of the control population.

Exclusion criteria

Exclusion Criteria:

  • Rheumatoid arthritis.
  • Ongoing infection in the hand or wrist.
  • History of gout or pseudogout in the hand.
  • Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
  • Chronic pain syndrome / centralized pain.
  • Intra-articular injection in the affected joint within 3 months. -Eaton Littler class 4 (symptomatic STT joint osteoarthritis).

The previously described exclusion criteria are identical to those of the control population. In addition patients with severe deformation of the trapezium, to the extent that it is not possible to place a prosthetic cup, will be excluded.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Other
    Arthroplasty

    Arthroplasty CMC-1

    Procedure: Arthroplasty CMC-1

Interventions

  • ProcedureArthroplasty CMC-1

    Touch Touch® dual-mobility Arthroplasty CMC-1 joint (Kerimed). Dorsal approach. Conical cup. Soft dressing 3 weeks. Loading allowed after 2 months.

06

What researchers measure

Primary outcomes

  1. Pain on load in the thumb 10 years postoperatively.

    Pain on load is rated with a self-administered 11-point numerical rating scale (NRS) 0-100 from the HQ-7 questionnaire. Higher score means more pain. The participants are asked to rate the pain the previous week.

    Time frame: 10 years postoperatively

Secondary outcomes

  1. Pain on load in the thumb 3 and 6 months, 1, 3, and 5 years postoperatively.

    Pain on load is rated with a self-administered 11-point numerical rating scale (NRS) 0-100 from the HQ-7 questionnaire. Higher score means mote pain. The participants are asked to rate the pain the previous week.

    Time frame: from enrollment to 5 years postoperatively

  2. HQ-8 score 3 and 6 months, 1,3, 5 and 10 years postoperatively

    Self-administered 11-point numerical rating scale (NRS) 0-100 symptoms questionnaire. Symptoms inlcude pain at rest, pain on motion, stiffness, weakness. Higher score means more symptoms. HQ-8 is the symptom-rating scale in the Swedish Hand surgical quality registry (HAKIR).

    Time frame: From enrollment to 10 years postoperatively

  3. Patient-rated Wrist and Hand (PRWHE) score 3 and 6 months, 1,3, 5 and 10 years postoperatively

    Patient-rated Wrist and Hand (PRWHE). Scale 0-100, higher score means more pain and disability,

    Time frame: From enrollment to 10 years postoperatively

  4. Distability of the Arm, Hand and Shoulder (DASH) score 3 and 6 months, 1,3, 5 and 10 years postoperatively

    Distability of the Arm, Hand and Shoulder (DASH) score range from 0 to 100, higher score means more disability,

    Time frame: From enrollment to 10 years postoperatively.

  5. Thumb range of motion 3 and 6 months, 1,3, 5 and 10 years postoperatively

    Palmar and radial abduction (degrees) of the first metacarpal measured with a goniometer

    Time frame: From enrollment to 10 years postoperatively

  6. Adverse events

    Number of particiant with a diagnosed infection, complex regional pain syndrome (CRPS), superficial radial sensory nerve injury or revision surgery required.

    Time frame: From enrollment to 10 years postoperatively.

  7. Thumb strength 1,3, 5 and 10 years postoperatively

    Key pinch and three-finger pinch measured with a pinch gauge (kilograms).

    Time frame: From enrollment to 10 years postoperatively

  8. Hand strength 1,3, 5 and 10 years postoperatively

    Full hand grip strength measured with Jamar (kilograms).

    Time frame: From enrollment to 10 years postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — A description of the variables collected throughout the trial and used in the results publication will be provided when the study is finished.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Beginning 3 months and ending 6 years after the publication of the final (10 years) results.

Access criteria: Data will be shared for systematic reviews/metananalyses. The statistical methods for those analyses need not to be approved by an independent review. A proposal that describes planned analyses must be submitted by e-mail to the corresponding author who will review requests for IPD sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Dec 2038, 160 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 160 months is above that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2025
First posted
Sep 17, 2025
StartActual
Aug 1, 2025
Primary completionEst.
Dec 31, 2038
CompletionEst.
Dec 31, 2038
Last update
Sep 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07178223
Responsible party
Maria Wilcke (Associate Professor, Karolinska Institutet) — Principal investigator
First posted
Sep 17, 2025
Start date
Aug 1, 2025
Primary completion
Dec 31, 2038 (estimated)
Completion
Dec 31, 2038 (estimated)
Last update
Sep 23, 2025

Study contacts

Maria Wilcke, MD, Associate professor
Contact
maria.wilcke@ki.se
+4681236022
Johanna Von Kieseritzky, MD, PhD
Contact
johanna.von.kieseritzky@ki.se
081236000
Maria Wilcke, Associate professor
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion